LENZ Therapeutics, Inc. — All Filings
327 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001815776-26-000013 | Mar 24, 2026 | — |
| 10-K | 10-K | 0001815776-26-000011 | Mar 24, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001815776-26-000008 | Mar 24, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016363 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000453 | Feb 5, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000687 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001815776-26-000003 | Jan 7, 2026 | — |
| 4 | FORM 4 | 0002015796-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0002015900-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001706176-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001713795-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001815776-25-000077 | Dec 12, 2025 | — |
| 4 | FORM 4 | 0002015796-25-000003 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0001950047-25-008982 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112625 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004990 | Nov 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-274461 | Nov 10, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000073 | Nov 10, 2025 | Nov 7, 2025 |
| 4 | FORM 4 | 0001815776-25-000072 | Nov 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001346824-25-000043 | Nov 7, 2025 | — |
| SCHEDULE 13G | — | 0000315066-25-002920 | Nov 7, 2025 | — |
| 10-Q | 10-Q | 0001815776-25-000071 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001815776-25-000069 | Nov 5, 2025 | — |
| SCHEDULE 13G | — | 0002012383-25-002599 | Oct 17, 2025 | — |
| 8-K | 8-K | 0001815776-25-000064 | Oct 8, 2025 | — |
| 4 | 4 | 0001193125-25-228493 | Oct 2, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001815776-25-000062 | Sep 30, 2025 | — |
| 4 | 4 | 0001193125-25-211363 | Sep 22, 2025 | Sep 18, 2025 |
| SCHEDULE 13D/A | — | 0001193125-25-211357 | Sep 22, 2025 | — |
| 4 | 4 | 0000950170-25-111529 | Aug 26, 2025 | Aug 22, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-110483 | Aug 20, 2025 | — |
| 4 | 4 | 0000950170-25-110163 | Aug 19, 2025 | Aug 15, 2025 |
| 8-K | 8-K | 0001815776-25-000059 | Jul 31, 2025 | — |
| 10-Q | 10-Q | 0001815776-25-000056 | Jul 30, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001815776-25-000054 | Jul 30, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-095617 | Jul 14, 2025 | — |
| 4 | 4 | 0000950170-25-095616 | Jul 14, 2025 | Jul 10, 2025 |
| 4 | 4 | 0000950170-25-092373 | Jul 1, 2025 | Jun 27, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-089455 | Jun 24, 2025 | — |
| 4 | 4 | 0000950170-25-088604 | Jun 20, 2025 | Jun 18, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-085511 | Jun 12, 2025 | — |
| 4 | 4 | 0000950170-25-085490 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016757 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000048 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000047 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000046 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000045 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000044 | Jun 11, 2025 | — |
| 4 | FORM 4 | 0001815776-25-000043 | Jun 11, 2025 | — |
| 8-K | 8-K | 0001815776-25-000036 | Jun 10, 2025 | — |